Prevention and treatment of viral infection and viral infection-induced organ failure

Compositions for and methods of preventing, reversing or treating viral infection-induced organ failure provided. The compositions are also suitable for treating and/or preventing COVID-19 and influenza. The compositions and methods employ MG53, which can be in the form of recombinant human MG53. Th...

Full description

Saved in:
Bibliographic Details
Main Authors Kenney, Adam D, Zhou, Xinyu, Ma, Jianjie, Cai, Chuanxi, Yount, Jacob S, Mokadam, Nahush A, Tan, Tao, Sermersheim, Matthew A, Whitson, Bryan A
Format Patent
LanguageEnglish
Published 14.12.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compositions for and methods of preventing, reversing or treating viral infection-induced organ failure provided. The compositions are also suitable for treating and/or preventing COVID-19 and influenza. The compositions and methods employ MG53, which can be in the form of recombinant human MG53. The MG53 may also be administered as a composition that expresses and releases MG53 after in vivo administration of said composition to a subject.
Bibliography:Application Number: US202117184781